[1]
Zinzani, P. 2009. 90Y-ibritumumab tiuxetan (Zevalin). Hematology Meeting Reports (formerly Haematologica Reports). 2, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i5.729.